S.C. Ropharma S.A. (BVB:RPH)

S.C. Ropharma Statistics

Total Valuation

S.C. Ropharma has a market cap or net worth of RON 97.14 million. The enterprise value is 247.35 million.

Market Cap	97.14M
Enterprise Value	247.35M

Important Dates

The next estimated earnings date is Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

S.C. Ropharma has 511.27 million shares outstanding. The number of shares has decreased by -0.89% in one year.

Current Share Class	511.27M
Shares Outstanding	511.27M
Shares Change (YoY)	-0.89%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.07%
Owned by Institutions (%)	8.61%
Float	177.64M

Valuation Ratios

The trailing PE ratio is 27.95.

PE Ratio	27.95
Forward PE	n/a
PS Ratio	0.07
PB Ratio	0.37
P/TBV Ratio	0.54
P/FCF Ratio	2.55
P/OCF Ratio	1.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.24, with an EV/FCF ratio of 6.49.

EV / Earnings	71.49
EV / Sales	0.17
EV / EBITDA	4.24
EV / EBIT	8.98
EV / FCF	6.49

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.70.

Current Ratio	1.06
Quick Ratio	0.64
Debt / Equity	0.70
Debt / EBITDA	3.16
Debt / FCF	4.83
Interest Coverage	5.10

Financial Efficiency

Return on equity (ROE) is 3.56% and return on invested capital (ROIC) is 3.96%.

Return on Equity (ROE)	3.56%
Return on Assets (ROA)	1.77%
Return on Invested Capital (ROIC)	3.96%
Return on Capital Employed (ROCE)	6.96%
Revenue Per Employee	838,283
Profits Per Employee	1,976
Employee Count	1,723
Asset Turnover	1.51
Inventory Turnover	5.10

Taxes

In the past 12 months, S.C. Ropharma has paid 15.10 million in taxes.

Income Tax	15.10M
Effective Tax Rate	61.93%

Stock Price Statistics

The stock price has increased by +9.83% in the last 52 weeks. The beta is 0.30, so S.C. Ropharma's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+9.83%
50-Day Moving Average	0.17
200-Day Moving Average	0.17
Relative Strength Index (RSI)	74.68
Average Volume (20 Days)	96,259

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S.C. Ropharma had revenue of RON 1.47 billion and earned 3.46 million in profits. Earnings per share was 0.01.

Revenue	1.47B
Gross Profit	315.18M
Operating Income	27.53M
Pretax Income	24.38M
Net Income	3.46M
EBITDA	45.64M
EBIT	27.53M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 48.63 million in cash and 184.12 million in debt, with a net cash position of -135.49 million or -0.27 per share.

Cash & Cash Equivalents	48.63M
Total Debt	184.12M
Net Cash	-135.49M
Net Cash Per Share	-0.27
Equity (Book Value)	262.43M
Book Value Per Share	0.48
Working Capital	37.95M

Cash Flow

In the last 12 months, operating cash flow was 52.37 million and capital expenditures -14.27 million, giving a free cash flow of 38.11 million.

Operating Cash Flow	52.37M
Capital Expenditures	-14.27M
Free Cash Flow	38.11M
FCF Per Share	0.07

Margins

Gross margin is 21.47%, with operating and profit margins of 1.88% and 0.24%.

Gross Margin	21.47%
Operating Margin	1.88%
Pretax Margin	1.66%
Profit Margin	0.24%
EBITDA Margin	3.11%
EBIT Margin	1.88%
FCF Margin	2.60%

Dividends & Yields

S.C. Ropharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.89%
Shareholder Yield	0.89%
Earnings Yield	3.56%
FCF Yield	39.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

S.C. Ropharma has an Altman Z-Score of 1.89 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.89
Piotroski F-Score	6